Skip to main content
ASTONEA LABS LIMITED logo

ASTONEA LABS LIMITED — Investor Relations & Filings

Ticker · 544409 ISIN · INE0TG901011 LEI · 3358004H58D5H7QRVM60 BSE.NS Manufacturing
Open in API
Filings indexed 8 across all filing types
Latest filing 2026-05-30 Regulatory Filings
Country IN India
Listing BSE.NS 544409

About ASTONEA LABS LIMITED

https://astonea.org/

Astonea Labs Limited is a specialized pharmaceutical and cosmeceutical organization focused on the research, development, and manufacturing of a diverse range of healthcare and personal care products. The company operates as a Contract Development and Manufacturing Organization (CDMO), providing end-to-end solutions from formulation development to commercial-scale production. Its product portfolio encompasses dermatology, including creams, ointments, and lotions, as well as oral solids and liquids such as tablets, capsules, and syrups. Astonea Labs emphasizes quality assurance through adherence to international standards, including WHO-GMP certifications. The firm serves both domestic and global markets, leveraging advanced manufacturing facilities to deliver high-quality therapeutic and aesthetic solutions. Its core competencies lie in innovative formulation techniques and a robust supply chain infrastructure.

Recent filings

Filing Released Lang Actions
Submission of Half-Yearly Disclosure on Related Party Transactions for the period ended 31.03.2026
Regulatory Filings Classification · 91% confidence The document is a submission to the stock exchange of the company’s related party transactions for the half year ended March 31, 2026, provided under SEBI (Listing Obligations and Disclosure Requirements) Regulations. It does not contain full interim financial statements or qualify as an Interim/Quarterly Report; rather, it is a statutory compliance disclosure filed with the exchange. This fits the general regulatory announcement category. Therefore, it should be classified as a Regulatory Filing (RNS).
2026-05-30 English
Statement of Deviation & Variation for the half year ended 31.03.2026
Regulatory Filings Classification · 85% confidence The document is a compliance disclosure submitted to the stock exchange under SEBI (LODR) Regulation 32, providing a ‘Statement of Deviation or Variation’ for utilization of IPO proceeds. It is not an Annual or Interim Report, not an earnings release, nor an officer certification, but rather a mandatory regulatory filing/disclosure under listing obligations. This fits the “Regulatory Filings” (RNS) category as a general compliance announcement.
2026-05-30 English
Intimation under Regulation 30- Re-appointment of Tax Auditor
Regulatory Filings Classification · 85% confidence The document is an exchange filing under SEBI LODR regulations announcing the re-appointment of the company’s tax auditor. It is not a financial report itself, nor is it a board/management change (the auditor is external), nor an audit report. This is a compliance/regulatory announcement pursuant to listing requirements, fitting the RNS (Regulatory Filings) category as a general regulatory announcement.
2026-05-30 English
Intimation under Regulation 30- Re-appointment of Cost Auditor
Regulatory Filings Classification · 90% confidence The document is an exchange filing under SEBI LODR Regulation 30 announcing the re-appointment of the company’s cost auditor. It is not the audit report itself, nor a financial statement, nor a management or board change in terms of directors or KMP. It is a required regulatory disclosure to the stock exchange. Thus it falls under the generic “Regulatory Filings” category.
2026-05-30 English
Intimation under Regulation 30- Re-appointment of Secretarial Auditor
Regulatory Filings Classification · 84% confidence The document is a formal exchange filing under SEBI LODR Regulation 30 announcing the re-appointment of the company’s Secretarial Auditor. It does not contain financial statements or report content itself, nor is it a management or board structural change (it pertains to an external auditor appointment). It is a routine regulatory disclosure to the stock exchange. This fits the general “Regulatory Filings” category.
2026-05-30 English
Audited Standalone Financial Results for the half year and year ended 31.03.2026
Regulatory Filings Classification · 87% confidence The document is a formal notice under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations announcing the outcome of a Board meeting and approval of audited financial results, auditor appointments, related‐party transaction approvals, and contract terminations. It serves as a regulatory announcement to the stock exchange rather than the full Annual Report, Interim Report, or standalone Audit Report. It does not contain the complete financial statements in narrative form but rather refers to attached schedules and reports. Thus, it is best classified as a general Regulatory Filing (RNS).
2026-05-30 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.